Dirk A. Schrijvers
Brasschaat, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Evaluating pain management practices for cancer patients among health professionals in cancer and supportive/palliative care units: a Belgian survey.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: March 10, 2024
End-of-Life Care in the Last Three Months before Death in Older Patients with Cancer in Belgium: A Large Retrospective Cohort Study Using Data Linkage.
Journal: Cancers
Published: May 23, 2023
Long-term health-care utilisation in older patients with cancer and the association with the Geriatric 8 screening tool: a retrospective analysis using linked clinical and population-based data in Belgium.
Journal: The lancet. Healthy longevity
Published: December 22, 2022
Functional status in older patients with cancer and a frailty risk profile: A multicenter observational study.
Journal: Journal of geriatric oncology
Published: February 02, 2022
Linking clinical and population-based data in older patients with cancer in Belgium: Feasibility and clinical outcomes.
Journal: Journal of geriatric oncology
Published: December 31, 2021
Incidence of falls and fall-related injuries and their predictive factors in frail older persons with cancer: a multicenter study.
Journal: BMC geriatrics
Published: December 11, 2021
Palliative Care and End-of-Life Issues in Elderly Cancer Patients With Head and Neck Cancer.
Journal: Frontiers in oncology
Published: September 01, 2021
Unplanned hospitalizations in older patients with cancer: Occurrence and predictive factors.
Journal: Journal of geriatric oncology
Published: July 27, 2020
The prognostic value of patient-reported Health-Related Quality of Life and Geriatric Assessment in predicting early death in 6769 older (≥70 years) patients with different cancer tumors.
Journal: Journal of geriatric oncology
Published: December 06, 2019
TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 18, 2018
Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis.
Journal: Genome medicine
Published: May 11, 2018
Circulating tumor cells and survival in abiraterone- and enzalutamide-treated patients with castration-resistant prostate cancer.
Journal: The Prostate
Published: September 21, 2017
Last Updated: 09/26/2026